With a recovery underway in its U.S. business, India's Mumbai-based Sun Pharmaceutical Industries Ltd., is scouting for a partner in China, where the government aims to drive down the cost of healthcare. China has rolled out a bulk drug procurement program that’s driving down prices and providing an opening for...
